Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma

<div>Immunohistochemical of glioma patients treated with apatinib. (a) Low expression of FABP7. (b) High expression of FABP7. (c) Numerical value of FABP7 expression.</div>

Disease Markers

fig7

Figure 7

Figure 7: Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma 